Form 4: Moderna President Stephen Hoge Reports Stock Transactions
SEC Form 4 Filing
Moderna's President, Stephen Hoge, reports the vesting of performance-based restricted stock units and subsequent tax withholding.
Summary
- Stephen Hoge, President of Moderna, reported changes in his beneficial ownership of Moderna stock on February 12, 2025.
- He acquired 5,734 shares of common stock upon the vesting of performance-based restricted stock units (PSUs) granted on March 1, 2022.
- 2,771 shares were withheld to satisfy tax obligations at a price of $30.93 per share.
- Following these transactions, Hoge directly owns 1,447,109 shares of Moderna common stock.
- He also has indirect ownership through Valhalla, LLC (4,116 shares) and a trust for his spouse and children (151,933 shares).
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Moderna.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Date of grant for the performance-based restricted stock units (2022 PSUs). |
| February 12, 2025 | Date of the reported transactions: vesting of PSUs and tax withholding. |
| February 14, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.